Catalyst Wire Dossier Catalyst Wire Dossier

BRIXADI

Buprenorphine · Braeburn Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BRIXADI, covering 2023-05-23 to 2025-12-22. Get the full timeline:

Most recent: FDA Approved: BRIXADI — Supplemental Application (Braeburn Inc.)

See pricing